3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note

In the current financial landscape, rising interest rates on long-term bonds, particularly the 10-year Treasury yield, are reshaping investment strategies. As of late September 2023, the 10-year Treasury yield climbed to approximately 5.3%, up from around 4.78% just a month earlier, and a significant increase from the previous year. This shift has made traditional high-valuation stocks less appealing, prompting investors to seek alternatives that offer both income and growth potential. In this context, we explore three income stocks—Pfizer (PFE), Energy Transfer (ET), and Plains All American Pipeline (PAA)—that not only trade under $30 but also provide dividend yields that surpass the Treasury yield.

The Impact of Rising Treasury Yields

Historically, long-term Treasury yields have had a profound influence on equity markets. The long-term average for the 10-year Treasury yield hovers around 4.25%. However, since the financial crisis of 2007-2008, investors have largely experienced lower rates, leading to a bullish environment for equities. Now, with yields on the rise, especially for investors nearing retirement, the focus has shifted toward wealth preservation rather than wealth generation.

Higher Treasury yields can make risk-on stocks—typically associated with growth and higher valuations—less attractive. This reality presents a unique opportunity for dividend-paying stocks, especially those in defensive sectors, offering a blend of income and stability. The following companies not only provide attractive dividend yields but also have the potential for price appreciation, making them appealing choices in a changing market.

Pfizer: A Biopharmaceutical Giant with Steady Returns

Dividend Overview - Dividend Yield: 6.19% - Annual Dividend: $1.72 - Dividend Increase Track Record: 16 years - Annualized 5-Year Dividend Growth: -13.20% - Dividend Payout Ratio: 226.32% (indicative of a high payout relative to earnings)

Pfizer is a well-known name in the biopharmaceutical industry, particularly recognized for its COVID-19 vaccine. The company boasts a diverse pipeline of approximately 95 drug candidates, creating an attractive proposition for investors looking for growth potential alongside dividends. However, it is crucial to note that not all candidates will successfully navigate the complexities of clinical trials, as seen in the recent failure of its lung cancer therapy.

Despite these challenges, Pfizer's stock remains appealing, trading below $30. As of 2023, shares have climbed approximately 14%, aligning closely with a consensus price target of $28.39. The company's commitment to increasing its dividend over the past 16 years adds to its attractiveness, especially in the current economic climate, where many investors seek reliable income sources.

Energy Transfer: Capitalizing on Midstream Demand

Dividend Overview - Dividend Yield: 6.65% - Annual Dividend: $1.36 - Dividend Increase Track Record: 4 years - Annualized 5-Year Dividend Growth: 4.29% - Dividend Payout Ratio: 92.52%

Energy Transfer operates in the midstream sector, which is crucial for transporting oil and natural gas. As high oil prices continue to drive inflation, understanding the dynamics of oil supply and demand becomes essential. While there is an abundance of oil, the challenge lies in refining and distributing it effectively. This transition from upstream exploration to midstream operations positions Energy Transfer favorably in an evolving energy landscape.

In 2023, Energy Transfer's stock saw a remarkable increase of over 20%, indicating strong market confidence. Analysts project a consensus price target of $24.36, suggesting additional growth potential. With a dividend yield nearing 7%, Energy Transfer provides a compelling option for investors looking for income alongside capital appreciation, particularly as the energy sector experiences a long-term bull cycle.

Plains All American Pipeline: Focused on Crude Oil Logistics

Dividend Overview - Dividend Yield: 7.03% - Annual Dividend: $1.67 - Dividend Increase Track Record: 5 years - Annualized 5-Year Dividend Growth: 11.05% - Dividend Payout Ratio: 46.26%

Plains All American Pipeline stands out as a focused player in the midstream sector, primarily transporting crude oil from the Permian Basin to refiners and export terminals along the Gulf Coast. Following its strategic decision to divest from its Canadian natural gas liquids business, Plains has streamlined its operations, enhancing its core focus on crude oil logistics. This shift positions the company as a toll road operator—its revenue is primarily driven by the volume of oil transported rather than the price per barrel.

In its latest earnings report for Q2 2023, Plains reported an adjusted EBITDA of $738 million, with the crude oil segment contributing significantly to this figure. The company has also raised its production growth outlook, which is expected to materialize in the coming years. Currently trading below $25, Plains has seen an impressive 32% increase in 2023, though analysts maintain a cautious outlook with a consensus Hold rating and a price target of around $25.43. However, recent adjustments by analysts, including a target revision by Mizuho to $30, indicate growing confidence in the company’s future prospects.

Broader Implications for Investors

As investors navigate the complexities of a rising interest rate environment, dividend-paying stocks like Pfizer, Energy Transfer, and Plains All American Pipeline offer a viable alternative to traditional bonds. The combination of attractive yields and the potential for capital appreciation makes these stocks particularly appealing for those seeking stability and income.

However, it’s imperative for investors to approach these opportunities with a balanced perspective. While dividend yields are enticing, factors such as dividend sustainability, financial health, and market conditions must be considered. The landscape is continually evolving, and remaining informed about macroeconomic trends, sector performance, and company fundamentals will be crucial for making sound investment decisions.

Conclusion: A Strategic Choice for Income Investors

In conclusion, as Treasury yields rise and traditional equity investments face challenges, the focus on dividend-paying stocks becomes increasingly relevant. Pfizer, Energy Transfer, and Plains All American Pipeline exemplify companies that not only offer attractive yields but also possess the potential for long-term growth.

Investors looking to bolster their portfolios with income-generating assets should consider these stocks, keeping in mind the importance of conducting thorough research and maintaining a diversified investment approach. With careful analysis and strategic positioning, investors can navigate the changing landscape and capitalize on opportunities in the income stock market.